← Back to all trials
Recruiting
NCT05616104
FLEX FIRST Registry Research Protocol
Conditions: Arteriovenous Fistula, Arteriovenous Graft, Fistula, Arterial Occlusive Diseases
Sex: All
Ages: 18 Years – N/A
Enrollment: 400
Sponsor: VentureMed Group Inc.
Location: United States
Summary
Prospective, observational study evaluating the clinical use and outcomes of the FLEX Vessel Prep (VP) system in arteriovenous fistulae or grafts presenting with clinical or hemodynamic abnormalities following 12 months post treatment.
Eligibility Criteria
Inclusion Criteria:Subject is ≥18 years of age.Subject is currently scheduled to undergo an endovascular intervention of arteriovenous fistula or graft due to clinical and hemodynamic abnormalities meeting the KDOQI Guidelines for AV access dysfunction:Elevated venous pressure during hemodialysis,Abnormal physical findings, andUnexplained decrease in delivered dialysis dose.Subject has a reasonable expectation of remaining on hemodialysis for ≥12 months.Subject is legally competent, informed of the study, voluntarily agrees to participate, and signs the informed consent form.Subject understands the study and is willing and able to comply with the follow-up requirements.Exclusion Criteria:Subject has a known or suspected systemic infection.Subject has a known or suspected infection of the hemodialysis graft.Subject has an untreatable allergy to radiographic contrast material.In the opinion of the operating physician, the subject's hemodialysis access is unsuitable for endovascular treatment.
Source: ClinicalTrials.gov (NCT05616104). StuddyBuddy aggregates publicly available trial information.